ZNF91 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.066750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.424400E-01
Normal-vs-Stage2
9.685800E-02
Normal-vs-Stage3
2.261200E-01
Normal-vs-Stage4
4.640400E-01
Stage1-vs-Stage2
1.317810E-02
Stage1-vs-Stage3
4.617700E-02
Stage1-vs-Stage4
2.060200E-01
Stage2-vs-Stage3
1.700550E-01
Stage2-vs-Stage4
1.636360E-01
Stage3-vs-Stage4
1.396500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.263980E-01
Normal-vs-AfricanAmerican
3.403400E-01
Normal-vs-Asian
1.036770E-01
Caucasian-vs-AfricanAmerican
8.406600E-01
Caucasian-vs-Asian
1.926020E-01
AfricanAmerican-vs-Asian
3.362000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.539170E-01
Normal-vs-Female
7.998400E-02
Male-vs-Female
1.570380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.481600E-01
Normal-vs-Age(41-60Yrs)
2.167600E-01
Normal-vs-Age(61-80Yrs)
6.633700E-02
Normal-vs-Age(81-100Yrs)
9.832100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.838400E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.757300E-03
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.786300E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.817600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.780600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.260800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.510200E-01
Normal-vs-Daily Drinker
8.322400E-02
Normal-vs-Weekly Drinker
8.257500E-02
Normal-vs-Occasional Drinker
1.390830E-01
Normal-vs-Social Drinker
4.124000E-01
Non Drinker-vs-Daily Drinker
9.564200E-01
Non Drinker-vs-Weekly Drinker
5.335600E-01
Non Drinker-vs-Occasional Drinker
4.358400E-01
Non Drinker-vs-Social Drinker
6.906300E-02
Daily Drinker-vs-Weekly Drinker
5.704200E-01
Daily Drinker-vs-Occasional Drinker
5.374400E-01
Daily Drinker-vs-Social Drinker
1.308180E-01
Weekly Drinker-vs-Occasional Drinker
2.793200E-01
Weekly Drinker-vs-Social Drinker
8.121700E-02
Occasional Drinker-vs-Social Drinker
3.336800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.329700E-02
Normal-vs-Grade 2
2.041800E-03
Normal-vs-Grade 3
5.497700E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.544800E-01
Grade 1-vs-Grade 3
4.956200E-01
Grade 1-vs-Grade 4
2.329700E-02
Grade 2-vs-Grade 3
8.744600E-01
Grade 2-vs-Grade 4
2.041800E-03
Grade 3-vs-Grade 4
5.497700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.144100E-02
Normal-vs-NonDiabetic
1.185970E-01
Diabetic-vs-NonDiabetic
2.338600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.528010E-01
Normal-vs-NoPancreatitis
8.589800E-02
Pancreatitis-vs-NoPancreatitis
9.899000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.806770E-01
Normal-vs-N1
7.591800E-02
N0-vs-N1
4.781000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.785600E-01
Normal-vs-TP53-NonMutant
6.035200E-01
TP53-Mutant-vs-TP53-NonMutant
1.211780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
